Quest Diagnostics Declares Quarterly Cash Dividend
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX) announced that its Board of Directors has declared a quarterly cash dividend of $0.86 per share.
The dividend is payable on October 21, 2026, to shareholders of record of Quest Diagnostics common stock as of October 6, 2026.
Positive
- Quarterly dividend declared at $0.86 per share, payable October 21, 2026
- Shareholder record date set for October 6, 2026, clarifying eligibility
Negative
- None.
Details
News Market Reaction – DGX
On Aug 13, the first trading day after this news, DGX closed 0.73% below the previous close.
Data tracked by StockTitan Argus for the Aug 13 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, we help reveal new avenues to identify and treat disease, empower healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three American adults each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302849946.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.